Neurotrophin stimulation of human melanoma cell invasion: Selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations

Advances in Enzyme Regulation

Volumn 37, Issue , 1997, Pages 111-134

  Marchetti, Dario ^a   Nicolson, Garth L ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Institute for Molecular Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BRAIN DERIVED NEUROTROPHIC FACTOR; EPIDERMAL GROWTH FACTOR; GLYCOSIDASE; HEPARAN SULFATE; HEPARANASE; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NERVE GROWTH FACTOR RECEPTOR P75; NEUROTROPHIN; NEUROTROPHIN 3;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; CANCER INVASION; CELL CULTURE; CHEMISTRY; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME SPECIFICITY; ENZYME SUBSTRATE; ENZYMOLOGY; EXTRACELLULAR MATRIX; GENETICS; HORMONE ACTION; HUMAN; HUMAN CELL; MELANOMA; METABOLISM; METASTASIS; MOUSE; NONHUMAN; PATHOLOGY; PROTEIN BINDING;

ELECTROPHORESIS, AGAR GEL; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; EXTRACELLULAR MATRIX; GLUCURONIDASE; GLYCOSIDE HYDROLASES; HEPARITIN SULFATE; HUMANS; MELANOMA; NEOPLASM INVASIVENESS; NERVE GROWTH FACTORS; NEUROTROPHIN 3; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN BINDING; RECEPTOR, NERVE GROWTH FACTOR; RECEPTORS, NERVE GROWTH FACTOR; SUBSTRATE SPECIFICITY; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0030768320     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2571(96)00019-2     Document Type: Conference Paper

References (53)

1. 1. K. TRYGGVASON, M. HOYHTYA and T. SALO, Proteolytic degradation of extracellular matrix in tumor invasion, Biochim. Biophys. Acta 907, 191-217 (1987).
2. 2. D. MOSCATELLI and D. B. RIFKIN, Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis, Biochim. Biophys. Acta 948, 67-85 (1988).
3. 3. G. L. NICOLSON, Metastatic tumor cell interactions with endothelium, basement membrane and tissue, Curr. Opin. Cell Biol. 1, 1009-1019 (1989).
4. 4. G. L. NICOLSON, M. NAKAJIMA, J. L. HERRMANN, D. G. MENTER, P. CAVANAUGH, J. S. PARK and D. MARCHETTI, Malignant melanoma metastasis to brain: role of degradative enzymes and responses to paracrine growth factors, J. Neuro-Oncol. 18, 139-149 (1994).
5. 5. R. V. IOZZO and A. D. MURDOCH, Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function, FASEB J. 10, 598-614 (1996).
6. 6. G. L. NICOLSON, D. G. MENTER, J. L. HERRMANN, P. CAVANAUGH, L. JIA, J. HAMADA, Z. YUN and D. MARCHETTI, Tumor metastasis to brain: role of endothelial cells, neurotrophin, and paracrine growth factors, Crit. Rev. Oncog. 5, 451-471 (1994).
7. 7. D. MARCHETTI, D. MENTER, L. JIN, M. NAKAJIMA and G. L. NICOLSON, Nerve growth factor effects on human and mouse melanoma cell invasion and heparanase production, Int. J. Cancer 55, 692-699 (1993).
8. 8. J. H. HERRMANN, D. G. MENTER, J. HAMADA, D. MARCHETTI, M. NAKAJIMA and G. L. NICOLSON, Mediation of NGF-stimulated extracellular matrix invasion by the human melanoma low-affinity p75 neurotrophin receptor: melanoma p75 functions independently of trkA, Mol. Biol. Cell 4, 1205-1216 (1993).
9. 9. M. V. CHAO, Growth factor signaling: where is the specificity?, Cell 68, 995-997 (1992).
10. 10. M. BOTHWELL, Tissue localization of nerve growth factor and nerve growth factor receptors, Curr. Top. Microbiol. Immunol. 165, 55-70 (1991).
11. 11. M. BARBACID, Nerve growth factor: a tale of two receptors, Oncogene 8, 2033-2044 (1993).
12. 12. F. LAMBALLE, R. KLEIN and M. BARBACID, TrkC, a new member of the Trk family of tyrosine protein kinase, is a receptor for neurotrophin-3, Cell 66, 967-979 (1991).
13. 13. H. THOENEN, C. BANDTLOW and R. HEUMAN, The physiological function of nerve growth factor in the central nervous system: comparison with the periphery, Rev. Physiol. Biochem. Pharmacol. 109, 145-178 (1987).
14. 14. D. MARCHETTI, I. MCCUTCHEON, H. I ROSS and G. L. NICOLSON, Inverse expression of neurotrophin receptor and neurotrophins at the invasion front of brain-metastatic human melanoma tissues, Int. J. Oncol. 7, 87-94 (1995).
15. 15. C. P. DIETRICH, L. O. SAMPIO and O. M. TOLEDO, Characteristic distribution of sulfated mucopolysaccharides in different tissues and in their respective mitochondria, Biochem. Biophys. Res. Comm. 71, 1-10 (1976).
16. 16. K. HEDMAN, M. KURKINEN, K. ALITALO, A. VAHERI, S. JOHANSSON and M. HÖÖK, Isolation of the pericellular matrix of human fibroblast cultures, J. Cell Biol. 81, 83-91 (1979).
17. 17. A. D. MURDOCH, B. LIU, R. SCHWARTING, R. S. TUAN and R. V. IOZZO, Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization, J. Histochem. Cytochem. 42, 239-249 (1994).
18. 18. I. R. COHEN, A. D. MURDOCH, M. F. NASO, D. MARCHETTI, D. BERD and R. V. IOZZO, Abnormal expression of perlecan in metastatic melanoma, Cancer Res. 54, 5771-5774 (1994).
19. 19. R. V. IOZZO, I. R. COHEN, S. GRASSEL and A. D. MURDOCH, The biology of perlecan: the multifaceted heparan sulfate proteoglycan of basement membranes and pericellular matrices., Biochem. J. 302, 625-639 (1994).
20. 20. R. V. IOZZO, Proteoglycans: structure, function and role in neoplasia, Lab. Invest. 53, 373-396 (1985).
21. 21. M. ISHIKAWA, B. FERNANDEZ and R. S. KERBEL, Highly pigmented human melanoma variant which metastasizes widely in nude mice, including to skin and brain, Cancer Res. 48, 4897-4903 (1988).
22. 22. L. H. ROHDE and D. D. CARSON, Heparin-like glycosaminoglycans participate in binding of a human trophoblastic cell line (JAR) to a human uterine epithelial cell line (RL95), J. Cell. Physiol. 155, 185-196 (1993).
23. 23. D. L. WAY, P. S. GROSSO, J. R. DAVIS, E. A. SURWIT and C. D. CHRISTIAN, Characterization of a new human endometrial carcinoma (RL195-2) established in tissue culture, In Vitro 19, 147-158 (1983).
24. 24. M. NAKAJIMA, T. IRIMURA and G. L. NICOLSON, A solid phase substrate of heparanase: its application to assay of human melanoma for heparan sulfate degradative activity, Anal. Biochem. 157, 162-171 (1986).
25. 25. E. ESCANDON, L. E. BURTON, E. SZONYI and K. NIKOLICS, Characterization of neurotrophin receptors by affinity crosslinking, J. Neurosci. Res. 34, 601-613 (1993).
26. 26. D. MARCHETTI and J. L. MCMANAMAN, Characterization of nerve growth factor binding to embryonic rat spinal cord neurons, J. Neurosci. Res. 27, 211-218 (1990).
27. 27. D. JOHNSON, A. LANAHAN, C. R. BUCK, A. SEHGAL, C. MORGAN, E. MERCER, M. BOTHWELL and M. CHAO, Expression and structure of the human NGF receptor, Cell 4, 545-554 (1986).
28. 28. H. SARIOLA, M. SAARMA, K. SAINIO, U. ARUMAAE, J. PALGI, A. VAAHTOKARI, I. THESLEFF and A. KARAVANOV, Dependence of kidney morphogenesis on the expression of nerve growth factor receptor, Science 254, 571-573 (1991).
29. 29. D. M. CARLSON, Structures and immunochemical properties of oligosaccharides isolated from pig submaxillary mucins, J. Biol. Chem. 243, 616-626 (1968).
30. 30. A. WASTESON, A method for the determination of the molecular weight and molecular weight distribution of chondroitin sulfate, J. Chromat. 59, 87-97 (1971).
31. 31. D. J. McQUILLAN, D. M. FINDLAY, A. M. HOCKING, M. YANAGISHITA, R. J. MIDURA and V. C. HASCALL, Proteoglycans synthesized by an osteoblast-like cell line (UMR 106-01), Biochem. J. 277, 199-206 (1991).
32. 32. J. V. SHIVELY and H. E. CONRAD, Formation of anydrous sugars in the chemical depolymerization of heparin, Biochemistry 15, 3932-3942 (1976).
33. 33. C. F. IBANEZ, T. EFBENDAL, G. BARBANY, J. MURRAY-RUST, T. L. BLUNDELL and H. PERSSON, Disruption of the low affinity receptor-binding site in NGF allows neuronal survival and differentiation by binding to the trk gene product, Cell 69, 329-341 (1992).
34. 34. R. N. FABRICANT, J. E. DE LARCO and G. L. TODARO, Nerve growth factor receptors on human melanoma cells in culture, Proc. Natl Acad. Sci. USA 74, 565-569 (1977).
35. 35. D. R. KAPLAN, B. L. HEMPSTEAD, Z. D. MARTIN, M. V. CHAO and L. F. PARADA, The trk proto-oncogene product: a signal transducing receptor for nerve growth factor, Science 252, 554-558 (1991).
36. 36. M. NAKAJIMA, T. IRIMURA, D. DI FERRANTE, N. DI FERRANTE and G. L. NICOLSON, Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines, Science 220, 611-613 (1983).
37. 37. I. SJOBERG and L. A. FRANSSON, Structural studies on heparan sulphate from human lung fibroblasts, Biochem. J. 191, 103-110 (1980).
38. 38. S. ERNST, R. LANGER, C. L. COONEY and R. SASISEKHARAN, Enzymatic degradation of glycosaminoglycans, Critical Rev. Biochem. Mol. Biol. 30, 387-444 (1995).
39. 39. D. MARCHETTI, D. McQUILLAN, W. C. SPOHN, D. D. CARSON and G. L. NICOLSON, Neurotrophin stimulation of human melanoma cell invasion: Selected NT enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations, Cancer Res. 56, 2856-2863 (1996).
40. 40. J. T. GALLAGHER, J. E. TURNBULL and M. LYON, Heparan sulphate proteoglycans, Biochem. Soc. Trans. 18, 207-209 (1990).
41. 41. L. A. FRANSSON, B. HAVSMARK and J. K. SHEEHAN, Self-association of heparan sulfate. Demonstration of binding by affinity chromatography of free chains on heparan sulfate-substituted agarose gels, J. Biol. Chem. 256, 3039-13043 (1981).
42. 42. B. F. SLOANE, J. R. DUNN and K.V. HONN, Calcium spike electrogenesis and other electrical activity in continuosly cultured small cell carcinoma of the lung, Science 212, 1151-1153 (1981).
43. 43. B. F. SLOANE, K. V. HONN, J. G. SADLER, W. A. TURNER, J. J. KIMPSON and J. D. TAYLOR, Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential, Cancer Res. 42, 980-986 (1982).
44. 44. M. NAKAJIMA, A. DE CHAVIGNY, C. E. JOHNSON, J. HAMADA, C. A. STEIN and G. L. NICOLSON, Suramin: a potent inhibitor of melanoma heparanase and invasion, J. Biol. Chem. 266, 9661-9666 (1991).
45. 45. M. NAKAJIMA, T. IRIMURA, N. DI FERRANTE and G. L. NICOLSON, Metastatic melanoma heparanase, J. Biol. Chem. 259, 2283-2290 (1984).
46. 46. D. G. MENTER, J. L. HERRMANN and G. L. NICOLSON, The role of trophic factors and autocrine/paracrine growth factors in brain metastasis, Clin. Exp. Metastasis 13, 67-88 (1995).
47. 47. J. K. PATEL, M. S. DIDOLKAR, J. W. PICKREN and R. H. MOORE, Metastatic pattern of malignant melanoma. A study of 216 autopsy cases, Am. J. Surg. 135, 807-810 (1978).
48. 48. M. HERLYN, Human melanoma: development and progression, Cancer Metastasis Rev. 9, 101-112 (1990).
49. 49. L. JIN, M. NAKAJIMA and G. L. NICOLSON, Immunochemical localization of heparanase in mouse and human melanomas, Int. J. Cancer 45, 1088-1095 (1990).
50. 50. M. NAKAJIMA, T. IRIMURA and G. L. NICOLSON, Heparanase and tumor metastasis, J. Cell. Biochem. 36, 157-167 (1986).
51. 51. S. C. WHITTEMORE and A. SEIGER, The expression, localization and functional significance of β-nerve growth factor in the central nervous system, Neurosci. Rev. 12, 439-464 (1987).
52. 52. F. HEFTI, Neurotrophic factor therapy for nervous system degenerative diseases, J. Neurobiol. 25, 1418-1435 (1994).
53. 53. D. G. MENTER, J. L. HERRMANN, D. MARCHETTI and G. L. NICOLSON, Involvement of neurotrophins and growth factors in brain metastasis formation, Invasion Metastasis 14, 372-384 (1995).